Abstract:Double-strand breaks (DSBs) can be efficiently removed from the DNA of higher eukaryotes by nonhomologous end-joining (NHEJ). Genetic studies implicate the DNA-dependent protein kinase (DNA-PK) in NHEJ, but the exact function of this protein complex in the rejoining reaction remains to be elucidated. We compared rejoining of DNA DSBs in a human glioma cell line, M059-J, lacking the catalytic subunit of DNA-PK (DNA-PKcs), and their isogenic but DNA-PK-proficient counterpart, M059-K. In both cell lines, rejoining of DNA DSBs was biphasic, with a fast and a slow component operating with a half-life of approximately 22 min and 12 h, respectively. Deficiency in DNA-PK activity did not alter the half-times of either of these components of rejoining but increased from 17 to 72% the proportion of DNA DSB rejoining with slow kinetics. DNA DSB rejoining was nearly complete in both cell lines, and there was only a small increase in the number of unrejoined breaks in M059-J as compared with M059-K cells after 30 h of incubation. Wortmannin radiosensitized to killing M059-K cells and strongly inhibited DNA DSB rejoining. Wortmannin did not affect the radiosensitivity to killing and produced only a modest inhibition in DNA DSB rejoining in M059-J cells, suggesting that, for these end points, DNA-PK is the principal target of the drug. These observations demonstrate that DNA-PK deficiency profoundly decreases the proportion of DNA DSB rejoining with fast kinetics but has only a small effect on the fraction remaining unrejoined. We propose that in higher eukaryotes, an evolutionarily conserved, independently active, but inherently slow NHEJ pathway is stimulated 30-fold by DNA-PKcs to rapidly remove DNA DSBs from the genome. The stimulation is expected to be of local nature and the presence of DNA-PKcs in the vicinity of the DNA DSB determines whether rejoining will follow fast or slow kinetics. Structural and regulatory functions of DNA-PKcs may mediate this impressive acceleration of DNA DSB rejoining, and regions of chromatin within a certain range from this large protein may benefit from these activities. We propose the term DNA-PK surveillance domains to describe these regions.

Congenital Bone Marrow Failure in DNA-PKcs Mutant Mice Associated with Deficiencies in DNA Repair

Spontaneous Tumor Development in Bone Marrow-Rescued Dna-Pkcs(3a/3a) Mice Due to Dysfunction of Telomere Leading Strand Deprotection

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair

PNKP is required for maintaining the integrity of progenitor cell populations in adult mice

Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice

DNA-PKcs suppresses illegitimate chromosome rearrangements

Nbs1‐mediated DNA damage repair pathway regulates haematopoietic stem cell development and embryonic haematopoiesis

Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence

Catalytic Subunit of DNA-dependent Protein Kinase: Impact on Lymphocyte Development and Tumorigenesis

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis

Differential Phosphorylation of DNA-PKcs Regulates the Interplay Between End-Processing and End-Ligation During Nonhomologous End-Joining

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Senataxin and DNA-PKcs Redundantly Promote Non-Homologous End Joining Repair of DNA Double Strand Breaks During V(D)J Recombination

Functional Redundancy Between the XLF and DNA-PKcs DNA Repair Factors in V(D)J Recombination and Nonhomologous DNA End Joining.

The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry.

DNA-dependent Protein Kinase Stimulates an Independently Active, Nonhomologous, End-Joining Apparatus.

The multifaceted functions of DNA-PKcs: implications for the therapy of human diseases

The Mammalian KU70 C-terminus SAP Domain Is Required to Repair Exogenous DNA Damage

Bmi1 Regulates Mitochondrial Function and the DNA Damage Response Pathway